Lubosan, Djurain .

HRN: 27-44-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2025
CEFUROXIME 750MG (VIAL)
07/09/2025
07/16/2025
IV
750mg
Q8h
UTI
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Urinary Tract    Compliance to guidelines: